on Cantourage Group SE (isin : DE000A3DSV01)
Cantourage Responds to Proposed Cannabis Law Changes with Strategic Moves
On October 8, 2025, following a resolution by the German government proposing significant changes to medical cannabis regulations, Cantourage Group SE announced strategies to address potential impacts. The draft bill mandates in-person consultations for prescriptions, which may temporarily lower the demand for cannabis flowers. Many patients currently rely on telemedicine services for their needs.
Philip Schetter, CEO of Cantourage, criticizes the proposed changes, suggesting they would complicate access to medical cannabis and risk industry growth in Germany. In response, Cantourage continues international expansion in markets like Poland and the UK, enhancing its resilience against domestic regulatory changes.
The company's ongoing product diversification in Germany aims to maintain patient supply amidst evolving regulations, affirming Cantourage's commitment to adaptive solutions for future challenges.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Cantourage Group SE news